Bryson R. Koehler - 09 Feb 2024 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
EVP, CTO, Prod & D&A Officer
Signature
/s/Lisa Stockard as Attorney-in-Fact
Issuer symbol
EFX
Transactions as of
09 Feb 2024
Transactions value $
$0
Form type
4
Filing time
13 Feb 2024, 16:10:47 UTC
Previous filing
17 Nov 2023
Next filing
14 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Award $0 +3.31K +19.09% $0.00 20.7K 09 Feb 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Award $0 +10.6K $0.00 10.6K 09 Feb 2024 Common Stock 10.6K $249.18 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3 Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025.